Zobrazeno 1 - 10
of 59
pro vyhledávání: '"Karen MacRae"'
Autor:
Michelle Bailey, John M. Murray, Sarah Pett, David A. Cooper, Sean Emery, John Zaunders, Karen MacRae, Anthony D. Kelleher
Publikováno v:
AIDS Research and Human Retroviruses. 26:653-661
HIV treatment with CCR5 receptor blockers may impact CCR5(+) cell distribution. T cell subsets, plasmacytoid dendritic cells (PDC), and antigen-specific [Mycobacteria tuberculosis/avium (M.TB/MAI), cytomegalovirus (CMV), Herpes simplex (HSV), HIV-Gag
Autor:
Sarah Pett, Karen MacRae, Julie M. Strizki, Richard Norris, Sean Emery, Amol Tendolkar, Kenneth M. Williams, Michael McCarthy, David A. Cooper
Publikováno v:
Antiviral Therapy. 14:111-115
Background SCH532706 is a novel small molecule chemokine receptor-5 (CCR5) antagonist with high in vitro potency (mean 90% inhibitory concentration [IC90] 0.15– 7.0 nM) against diverse HIV type-1 (HIV-1) isolates. Methods A single arm study was und
Autor:
Alan Winston, Sean Emery, Kenneth M. Williams, Malte Schutz, Matthew Law, Karen MacRae, David A. Cooper, Claudette S. Satchell, Patrick W. G. Mallon
Publikováno v:
Clinical Infectious Diseases. 44:1475-1483
Background. Toxicities observed with current combination antiretroviral therapy (CART) warrant a search for novel options, such as class-sparing regimens. Ritonavir-boosted double-protease inhibitor (PI)-only regimens are such an option but are prone
Autor:
Mark Bloch, David A. Cooper, Sarah Pett, John E. Ray, Sean Emery, Handan Wand, Dianne Carey, Kate Beileiter, Karen MacRae, Mark A. Boyd
Publikováno v:
Journal of acquired immune deficiency syndromes (1999). 60(2)
Background: New antiretroviral drug classes provide opportunities to explore novel regimens. Methods: HIV+ adults (l50 copies/mL) receiving atazanavir (ATV) were randomized to raltegravir (RAL) 400 mg + ATV 300 mg twice daily (q12h) for 4 weeks follo
Autor:
John, Pattison, Karen, MacRae
Publikováno v:
Nursing times. 98(35)
Current government health policy calls for increased collaboration between acute and primary care, and between the NHS and the independent sector. This article describes an initiative in which an NHS trust contracted an independent company to provide
Autor:
Wendt, Chris H.1,2 (AUTHOR) wendt005@umn.edu, Castro-Pearson, Sandra3 (AUTHOR), Proper, Jennifer3 (AUTHOR), Pett, Sarah4 (AUTHOR), Griffin, Timothy J.5 (AUTHOR), Kan, Virginia6 (AUTHOR), Carbone, Javier7 (AUTHOR), Koulouris, Nikolaos8 (AUTHOR), Reilly, Cavan3 (AUTHOR), Neaton, James D.3 (AUTHOR)
Publikováno v:
PLoS ONE. 4/2/2021, Vol. 16 Issue 4, p1-12. 12p.
Autor:
Trevillyan, Janine M.1 janine.trevillyan@monash.edu, Wong, Gerard2, Puls, Rebekah3, Petoumenos, Kathy4, Emery, Sean4,5, Mellett, Natalie A.2, Mundra, Piyushkumar A.2, Meikle, Peter J.2, Hoy, Jennifer F.1,6, null, null
Publikováno v:
PLoS ONE. 8/29/2018, Vol. 13 Issue 8, p1-16. 16p.
Autor:
Lynfield, Ruth1 Ruth.Lynfield@state.mn.us, Davey, Richard2, Dwyer, Dominic E.3, Losso, Marcelo H.4, Wentworth, Deborah5, Cozzi-Lepri, Alessandro6, Herman-Lamin, Kathy5, Cholewinska, Grazyna7, David, Daniel8, Kuetter, Stefan9, Ternesgen, Zelalem10, Uyeki, Timothy M.11, Lane, H. Clifford2, Lundgren, Jens12, Neaton, James D.5
Publikováno v:
PLoS ONE. Jul2014, Vol. 9 Issue 7, p1-15. 15p.
Publikováno v:
Canadian Journal of Disability Studies; 2020, Vol. 9 Issue 2, p38-76, 40p
Autor:
Calmy, A.1,2 acalmy@gmail.com, Bloch, M.3, Wand, H.4, Delhumeau, C.2, Finlayson, R.5, Rafferty, M.1, Norris, R.1, Hirschel, B.2, Cooper, D. A.1,4, Carr, A.1
Publikováno v:
HIV Medicine. Sep2010, Vol. 11 Issue 8, p493-501. 9p. 1 Diagram, 3 Charts, 1 Graph.